HOME ABOUT US TECHNOLOGIES PRODUCT PIPELINE LEAD COMPOUND INVESTORS CAREERS CONTACT

News & Updates

• 05.25.11 -
• Advanomics Corporation announces receipt of a new patent in the all-important field of RNA Technology

Our Lead Anti-Tumor Compound
Difluoro-Etoposide™
(Adva-27a)